期刊文献+

结直肠癌患者手术前后循环DNA水平的变化及其意义 被引量:6

Alteration of pre- and postoperative circulating DNA level in colorectal cancer patients and its significance
原文传递
导出
摘要 目的:探讨结直肠癌患者手术前后循环DNA水平的变化及其临床意义。方法:检测42例结直肠癌患者术前、术后3,14,30 d循环DNA水平,并检测同期14例健康体检者循环DNA水平作为对照。结果:结直肠癌患者术前循环DNA水平明显高于健康人[(92.25±46.88)ng/mL vs.(22.14±16.16)ng/mL](P<0.01);结直肠癌术前循环DNA水平在不同年龄、性别、肿瘤部位分组间差异无统计学意义(P=0.293,P=0.244,P=0.135)。结直肠癌患者术后3 d循环DNA水平达(114.95±62.41)ng/mL,较术前明显升高(P<0.01),但在术后14,30 d分别为(38.50±37.71)ng/mL与(31.69±41.48)ng/mL,明显低于术前(均P<0.01)。结论:循环DNA水平在结直肠癌患者中升高,且术后早期一过性进一步升高,随后明显下降。循环DNA水平有望成为结直肠癌术后监测肿瘤状态和评价疗效的标志物。 Objective: To investigate the alteration of circulating DNA level in colorectal cancer patients before and after surgery and its clinical significance. Methods: The circulating DNA levels in 42 patients with colorectal cancer were detected before and on 3, 14 and 30 d after surger)5 and the circulating DNA levels in 14 healthy subjects undergoing health maintenance examination during the same period were determined as control.Results: The preoperative circulating DNA level in colorectal cancer patients was significantly higher than that in healthy subjects [(92.25±46.88) ng/mL vs. (22.14±16.16) ng/mL] (P〈0.01), and the preoperative circulating DNA level in colorectal cancer patients showed no significant difference between or among the groups stratified by age, sex and tumor location (P=0.293, P=0.244 and P=0.135). In colorectal cancer patients, the circulating DNA level on postoperative day (POD) 3 reached (114.95±62.41) ng/mL, which was significantly higher than that before surgery (P〈0.01), but on POD 14 and 30 it was (38.50±37.71) ng/mL and (31.69±41.48) ng/mL respectively, and both were significantly lower than that before surgery (both P〈0.01). Conclusion: The circulating DNA level is elevated in colorectal cancer patients, and it is further increased transiently in early postoperative stage and then markedly decreased. It may probably be used as an indicator for postoperative tumor status and efficacy evaluation in these patients.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2013年第12期1627-1630,共4页 China Journal of General Surgery
关键词 结直肠肿瘤 循环DNA 生物学标记 Colorectal Neoplasms Circulating DNA Biological Markers
  • 相关文献

参考文献20

  • 1Leon SA,Shapiro B,Sklaroff DM. Free DNA in the serum of cancer patients and the effect of therapy[J].{H}CANCER RESEARCH,1977,(03):646-650.
  • 2Diehl F,Schmidt K,Choti MA. Circulating mutant DNA to assess tumor dynamics[J].{H}Nature Medicine,2008,(09):985-990.
  • 3Suzuki N,Kamataki A,Yamaki J. Characterization of circulating DNA in healthy human plasma[J].{H}Clinica Chimica Acta,2008,(1-2):55-58.
  • 4Jahr S,Hentze H,Englisch S. DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells[J].{H}CANCER RESEARCH,2001,(04):1659-1665.
  • 5Stroun M,Lyautey J,Lederrey C. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release[J].{H}Clinica Chimica Acta,2001,(1-2):139-142.
  • 6Gormally E,Caboux E,Vineis P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis:practical aspects and biological significance[J].{H}Mutation Research,2007,(2-3):105-117.
  • 7Gal S,Fidler C,Lo YM. Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR[J].{H}British Journal of Cancer,2004,(06):1211-1215.
  • 8Sozzi G,Conte D,Mariani L. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients[J].{H}CANCER RESEARCH,2001,(12):4675-4678.
  • 9Cheng C,Omura-Minamisawa M,Kang Y. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy[J].{H}CANCER SCIENCE,2009,(02):303-309.
  • 10Gautschi O,Bigosch C,Huegli B. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy[J].{H}Journal of Clinical Oncology,2004,(20):4157-4164.

二级参考文献13

  • 1Leon SA,Shapiro B,Sklaroff DM,et al.Free DNA in the serum of cancer patients and the effect of therapy.Cancer Res,1977,37:646-650.
  • 2Jahr S,Hentze H,Englisch S,et al.DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells.Cancer Res,2001,61:1659-1665.
  • 3Anker P,Lyautey J,Lederrey C,et al.Circulating nucleic acids in plasma or serum.Clin Chim Acta,2001,313:143-146.
  • 4Anker P,Mulcahy H,Chen XQ,et al.Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients.Cancer Metastasis Rev,1999,18:65-73.
  • 5Wong IH,Zhang J,Lai PB,et al.Quantitative analysis of tumorderived methylated p16INK4a sequences in plasma,serum,and blood cells of hepato cellular carcinoma patients.Clin Cancer Res,2003,9:1047-1052.
  • 6Szymanska K,Lesi OA,Kirk GD,et al.Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia,West Africa.Int J Cancer,2004,110:374-379.
  • 7Silva JM,Dominguez G,Garcia JM,et al.Presence of tumor DNA in plasma of breast cancer patients:clinicopathological correlations.Cancer Res,1999,59:3251-3256.
  • 8Allan JM,Hardie LJ,Briggs JA,et al.Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer.Int J Cancer,2001,91:359-365.
  • 9Lin JC,Chen KY,Wang WY,et al.PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis:effect of enzyme and sampling.Head Neck,2002,24:591-596.
  • 10Dahse R,Utting M,Werner W,et al.TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum,plasma and urine samples.Int J Oncol,2002,20:107-115.

共引文献14

同被引文献78

  • 1任宁,钦伦秀,屠红,刘银坤,张博恒,汤钊猷.肝细胞癌病人血浆循环DNA定量分析及其临床意义[J].复旦学报(医学版),2005,32(2):134-138. 被引量:10
  • 2严子禾,潘世扬,陈丹,魏源华,高丽,谢而付,黄珮珺,戎国栋,胡宜蘅,童明庆.4种血浆游离DNA提取方法的比较[J].临床检验杂志,2006,24(5):363-365. 被引量:27
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin, 2011,61 (2) : 69-90. DOI: 10. 3322/caac. 20107.
  • 4Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as bio- markers in cancer patients[ J]. Nat Rev Cancer, 2011, 11 (6) : 426- 437. DO1 : 10. 1038/nrc3066.
  • 5Mouliere F, Thierry AR. The importance of examining the proportion of circulating DNA originating from tumor, mict, oenviromnent and nor- mal cells in colorectal cancer patients [ J]. Expert Opin Biol Ther, 2012, 12Suppl 1: $209-$215. DOI: 10. 1517/14712598. 2012. 688023.
  • 6Bernatsky S, Ramsey-Goldman R, Joseph L, et al. Lymphoma risk in systemic lupus:effects of disease activity versus treatment [ J ]. Ann Rheum Dis, 2014, 73 ( 1 ) : 138-142. DOI: 10. 1136/annrheumdis- 2012-202099.
  • 7Kaiser J. Medicine. Keeping tabs on tumor DNA[J]. Science, 2010, 32 ( 5969 ) : 1074. DOI : 10,1126/seience. 327. 5969,1074.
  • 8Itzkowitz S, Brand R, Jandorf L, et al. A simplified, noninvasive stool DNA test for eoloreetal cancer detection [ J]. Am J Gastroen- terol, 2008, 103 ( 11 ) : 2862-2870. DOI: 10. llll/j. 1572-0241. 2008.
  • 902088. x. Kanthan R, Senger JL, Kanthan SC. Fecal molecular markers for coloreetal cancer screening [ J]. Gastroenterol Res Praet, 2012 (2011 ) : 184343. DOI : 10,1155/2012/184343.
  • 10Hao TB, Shi W, Shen XJ, et al. Circulating cell-free DNA in serumas a biomarker for diagnosis and prognostic prediction of colorectal cancer[J]. Br J Cancer, 2014, 111 (8): 1482-1489. DOI:10,1038/bje. 2014. 470.

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部